These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 31862895)

  • 1. Prioritization of intervention domains to prevent cardiovascular disease: a country-level case study using global burden of disease and local data.
    Wilson N; Cleghorn C; Nghiem N; Blakely T
    Popul Health Metr; 2023 Jan; 21(1):1. PubMed ID: 36703150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Unified Model of Age-Related Cardiovascular Disease.
    Fossel M; Bean J; Khera N; Kolonin MG
    Biology (Basel); 2022 Dec; 11(12):. PubMed ID: 36552277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.
    Behbodikhah J; Ahmed S; Elyasi A; Kasselman LJ; De Leon J; Glass AD; Reiss AB
    Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential impact of COVID-19 related unemployment on increased cardiovascular disease in a high-income country: Modeling health loss, cost and equity.
    Nghiem N; Wilson N
    PLoS One; 2021; 16(5):e0246053. PubMed ID: 34043626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which elderly patients should be considered for anti-hypertensive treatment? An evidence-based approach.
    Jackson R
    J Hum Hypertens; 1998 Sep; 12(9):607-13. PubMed ID: 9783489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and health effects of adding functional foods containing phytosterols/-stanols to statin therapy in the prevention of cardiovascular disease.
    Eussen SR; Feenstra TL; Toxopeus IB; Hoekstra J; Klungel OH; Verhagen H; van Kranen HJ; Rompelberg CJ
    Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S91-100. PubMed ID: 21816151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk.
    Nghiem N; Knight J; Mizdrak A; Blakely T; Wilson N
    Sci Rep; 2019 Dec; 9(1):19562. PubMed ID: 31862895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cataract surgery for falls prevention and improving vision: modelling the health gain, health system costs and cost-effectiveness in a high-income country.
    Boyd M; Kvizhinadze G; Kho A; Wilson G; Wilson N
    Inj Prev; 2020 Aug; 26(4):302-309. PubMed ID: 31221667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The health gains and cost savings of dietary salt reduction interventions, with equity and age distributional aspects.
    Nghiem N; Blakely T; Cobiac LJ; Cleghorn CL; Wilson N
    BMC Public Health; 2016 May; 16():423. PubMed ID: 27216490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health gains, costs and cost-effectiveness of a population-based screening programme for abdominal aortic aneurysms.
    Nair N; Kvizhinadze G; Jones GT; Rush R; Khashram M; Roake J; Blakely A
    Br J Surg; 2019 Jul; 106(8):1043-1054. PubMed ID: 31115915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population].
    Si YQ; Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Liu JJ; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):443-449. PubMed ID: 29930411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of tax and tobacco-free generation on health-adjusted life years in the Solomon Islands: a multistate life table simulation.
    Singh A; Petrović-van der Deen FS; Carvalho N; Lopez AD; Blakely T
    Tob Control; 2020 Jul; 29(4):388-397. PubMed ID: 31227649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Country-level Health and Cost Impacts of Legalizing Domestic Sale of Vaporized Nicotine Products.
    Petrović-van der Deen FS; Wilson N; Crothers A; Cleghorn CL; Gartner C; Blakely T
    Epidemiology; 2019 May; 30(3):396-404. PubMed ID: 30789423
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.